Wheeler Cameron 4/A
4/A · Homology Medicines, Inc. · Filed Jun 11, 2019
Insider Transaction Report
Form 4/AAmended
Wheeler Cameron
Director
Transactions
- Award
Option (Right to Buy)
2019-06-06+15,580→ 15,580 total(indirect: See footnote)Exercise: $19.51Exp: 2029-06-06→ Common Stock (15,580 underlying)
Footnotes (2)
- [F1]This option shall vest and become exercisable on the earlier of June 6, 2020 or the day immediately prior to the date of the next annual meeting of the Company's stockholders occurring after the date of grant, in either case subject to the Non-Employee Director continuing in service on the Board as a Non-Employee Director through each such vesting date.
- [F2]The Reporting Person, a partner at Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities. The Reporting Person holds the option for the benefit, and at the direction, of Deerfield Management Company, L.P.